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patients. There were 30 synchronous tumors and seven 
metachronous PGs diagnosed 2–18 years after removal 
of the first tumor. Single metachronous mediastinal PG 
occurred. All patients had at least one tumor removed, 
with histopathological confirmation of the diagnosis. One 
patient had positive history of familial PGs. Carotid PGs 
are most common multiple paragangliomas. Radiological 
survey of the head and neck is required to detect multi-
centric tumors. Metachronous mediastinal and abdominal 
tumors may occur. Regular, prolonged follow-up is essen-
tial to identify metachronous PGs and possible postopera-
tive gradual ICA occlusion.
Keywords Imaging · Metachronous · Multiple tumors · 
Paraganglioma · Surgery · Synchronous
Introduction
Paragangliomas (PGs) are slowly growing, usually 
benign neoplasms, which arise from extra-adrenal para-
ganglionic tissue derived from neural crest cells [1, 2]. 
In the head and neck region, parasympathetic-associated 
PGs may be located in four primary sites: the carotid 
bifurcation (carotid PG), the jugular bulb (jugular PG), 
the tympanic plexus (tympanic PG) and the vagal gan-
glia (vagal PG). Other, less common sites of origin are 
the nose, larynx, parotid gland, orbit and thoracic inlet 
[3]. Most of the tumors in the head and neck belong to 
the group of nonchromaffin PGs, as they do not secrete 
catecholamines and do not show catecholamine by chro-
maffin staining [4, 5].
It is difficult to evaluate the incidence of paraganglio-
mas due to their rarity. It is estimated that they represent 
0.012 % of all human tumors and 0.6 % of head and neck 
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neoplasms [1]. Familial occurrence of PGs is well recog-
nized and caused by mutations in succinate dehydrogenase 
(SDH) subunit genes [6, 7]. These tumors may be associ-
ated with several inherited syndromes: multiple endocrine 
neoplasia (MEN), neurofibromatosis type 1 (NF1), von 
Hippel-Lindau syndrome (VHL), paraganglioma syn-
drome (PGS) [1, 3]. Clinically very important are multiple 
paragangliomas, which may develop in the sporadic form 
of the disease, but are more common in heredofamilial 
variety.
The aim of the study was to analyze the incidence, diag-
nostic and therapeutic management of patients with multi-
ple paragangliomas of the head and neck.
Materials and methods
Between 1983 and 2013, 84 patients with head and neck 
paragangliomas were diagnosed and treated in our tertiary 
referral university hospital. Fourteen (16.6 %) of these 
patients had two or more tumors, synchronous or metachro-
nous within 4–21 years of follow‑up.
Clinical data of these 14 patients with multiple PGs 
were reviewed to evaluate the diagnosis, location, stage and 
management strategy. The study was approved by the insti-
tutional ethical committee.
All patients with multiple paragangliomas had at least 
one tumor removed, with histopathological confirmation of 
the diagnosis. There were nine females and five males and 
the age of patients ranged from 14 to 62 years.
In total MRI was performed in 13 patients, CT in 
10 patients and ultrasound study (US) in 12 patients. 
Superselective transarterial embolization of tumor vessels 
was performed only in patients with jugular PG, 2 or 3 days 
before surgery. Jugular PGs were classified according to 
Fisch staging system [8] (Table 1).
Results
Symptoms
Symptoms of jugular PGs included ipsilateral hearing 
loss and tinnitus. Evaluation of the tympanic membrane 
revealed bulging and/or pulsating polyp. Carotid PGs on 
clinical examination presented as palpable, non tender 
lateral neck masses. Vagal PGs manifested with a palpa-
ble, painless mass in the upper neck. In advanced tumors 
medial protrusion into the oropharynx was observed. Three 
patients presented with facial nerve palsy and four patients 
with lower cranial nerve palsy (IX–XII). In 8 patients 13 
small synchronous tumors were asymptomatic, and discov-
ered with CT, MRI or ultrasound.
Imaging
Carotid PGs were diagnosed on the basis of US, CT and/or 
MRI. US depicted carotid PGs in all patients evaluated with 
this modality. All tumors were located within the carotid 
bifurcation, caused splaying of the internal (ICA) and exter-
nal carotid arteries (ECA) and had multiple blood vessels 
with arterial blood flow of low-resistance pattern on Dop-
pler study. US was not sufficient for reliable diagnosis of 
vagal PGs.
Table 1  Classification of 
temporal paragangliomas by 
Fisch et al. [8]
Stage Description
Class A Tumors arise along the tympanic plexus on the promontory of the middle ear. Minimal erosion of 
the promontory may occur
Class B Tumors originate in the canalis tympanicus of the hypotympanum and invade the middle ear and 
mastoid. The carotid foramen and canal are intact. Tumors invade the bone of the hypotympa-
num, but the cortical bone over jugular bulb is intact
Class C Tumors originate in the dome of the jugular bulb and destroy overlying cortical bone and may 
spread inferior, posterior, superior, lateral and medial
C1 Erosion of the carotid foramen, without invasion of the carotid artery
C2 Destruction of the vertical carotid canal between the carotid foramen and the carotid bend
C3 Involvement of the horizontal portion of the carotid artery, without the foramen lacerum
C4 Involvement of the foramen lacerum and along the carotid artery of the cavernous sinus
Class D Class D indicates the intracranial extension of the tumor. Intracranial extension may be extradural 
(De) or intradural (Di)
De 1 Tumors displace the posterior fossa dura <2 cm
De 2 Tumors displace the posterior fossa dura >2 cm. The tentorium may be pushed superiorly
Di 1 Intradural extension <2 cm. No involvement of the pontomedullary brainstem
Di 2 Intradural extension >2 cm, attached to the vascular and neural structures of the brainstem
Di 3 Neurosurgically unresectable tumors
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All jugular and vagal PGs were diagnosed on the basis 
of high resolution CT and MRI (Fig. 1). In all jugular PGs, 
CT scans showed irregular widening of the jugular foramen 
with cortex erosion and permeative destruction of the sur-
rounding bone. Vagal PGs did not cause erosion or widening 
of the jugular foramen. In all PGs, CT scans demonstrated 
solid tumors with intensive, homogeneous contrast enhance-
ment. On MRI all PGs showed intermediate to high signal 
intensity on T2-weighted images, low to intermediate sig-
nal intensity on T1-weighted images and intensive contrast 
enhancement. Intratumoral flow voids were visible in 11 
PGs. Angiography in all cases demonstrated extremely vas-
cular tumors with intense blush and apparent arteriovenous 
shunts in five cases (Fig. 2). All tumors were supplied by the 
ECA and in two patients by the branches of the ICA.
Tumor characteristics
There was a total number of 37 head and neck tumors in 
14 patients. There were 20/37 (54.0 %) carotid PGs, 9/37 
(24.3 %) jugular PGs and 8/37 (21.7 %) vagal PGs. Carotid 
PGs were observed in 12/14 (86 %) patients and in 8/14 
(57 %) cases bilateral tumors occurred. Vagal PGs devel-
oped in 7/14 (50 %) patients and bilateral tumors were 
found in 1/14 (7 %) case. Jugular PGs occurred in 9/14 
(64 %) patients, no bilateral tumors were observed.
There were 30 synchronous tumors and seven metachro-
nous head and neck PGs diagnosed 2–18 years after 
removal of the first tumor. One patient in the group (No. 7, 
MM) had 5 PGs: carotid, vagal and jugular tumors on one 
side, a carotid tumor on the opposite side and a metachro-
nous aorticopulmonary PG. One patient (No. 8, JA) devel-
oped three synchronous and one metachronous PG 5 years 
after resection of pheochromocytoma.
One patient (No. 8, JA) had positive history of familial 
PGs. No secretory activity was found.
Treatment strategy
All patients with multiple PGs underwent surgical treat-
ment. Symptomatic tumors or tumors with radiologically 
confirmed progression were removed. Multiple PGs on one 
side of the head and neck were removed in single-stage. In 
small, symptomless tumors without evidence of progres-
sion a wait and scan policy was employed. In bilateral PGs 
after extirpation of one side tumor the ICA patency and 
cranial nerve functions were monitored. Only in case of 
normal clinical and radiological findings the second stage 
Fig. 1  Contrast-enhanced sagital CT reconstruction well demon-
strates double PG on one side of the head and neck: advanced intra-
dural jugular PG (arrow) and vagal PG (asterisk) with anterior dis-
placement of the internal carotid artery (arrowheads)
Fig. 2  Common carotid angiography, lateral view, shows three syn-
chronous hypervascular tumors: jugular PG (curved arrow), vagal 
PG (arrow) and carotid PG (asterisk). Branches of the ECA: a facial 
artery, b lingual artery, c internal maxillary artery, d occipital artery
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operation of the contralateral tumor was considered. Other-
wise conservative a wait and scan policy was adopted.
Follow-up
One patient (No. 2, RA) with jugular, vagal and carotid 
PGs on one side of the head and neck died due to the 
ICA rupture 5 days after single-stage removal of the three 
tumors. Patient No. 5 (DA) with advanced temporal para-
ganglioma (Fisch C1Di2) and severe neurological deficits 
underwent nonradical surgery and died 3 years after the 
operation due to progression of the disease. Another patient 
(No. 6, DM) died 4 years after surgery of advanced jugu-
lar and vagal PGs (Fisch C4Di1) because of breast cancer. 
In other patients control of the disease has been achieved 
up to 21 years follow-up, e.g. patients are without clinical 
and radiological signs of progression of the disease. Two 
patients with large bilateral carotid PGs (No. 11 KJ, No. 12 
WM) after removal of one tumor and repair of the carotid 
injury developed gradual occlusion of the ipsilateral ICA, 
without neurological deficits.
Detailed clinical data of the patients with multiple PGs 
are depicted in Table 2.
Discussion
Multiple paragangliomas may occur synchronously or 
metachronously. Multicentric tumors occur in 10–20 % 
of all head and neck paragangliomas [2, 9–11]. However, 
reports of much higher incidence of multiple tumors, like 
40 % for sporadic form and 80 % for familial variety, can 
be found in the literature [5, 12, 13]. Bilateral tumors have 
been reported in 4.4 % of sporadic and 31.8 % of familial 
cases [1]. In the total number of 84 paraganglioma patients 
treated in our institution, 16.6 % of patients had multiple 
tumors and vast majority of them were synchronous. It is 
noteworthy that some multicentric PGs are asymptomatic 
at presentation of the disease. Gardner et al. [5] discovered 
13 unsuspected paragangliomas in the total number of 23 
tumors diagnosed. There were 13 asymptomatic PGs in 
our group of 14 patients with 37 multiple paragangliomas. 
The most common multiple paragangliomas are carotid 
body tumors, which constitute ~10 % of sporadic cases 
and 25–33 % of familial cases [2, 13]. In our study carotid 
PGs represented more than a half of all tumors and 57 % of 
patients had bilateral carotid PGs. According to Van Baars 
et al. [14], at least one carotid body tumor was found in 
every patient with multiple PGs. In two patients (No. 5 
and No. 6) from our group no carotid body tumors were 
detected. However, in two other patients (No. 1 and No. 
3) carotid PGs developed as metachronous tumors 5 and 
18 years after resection of temporal bone and vagal tumors, 
respectively. Multiple vagal PGs represent about 17 % of 
all cases [2]. Bilaterality is uncommon, with eight cases of 
bilateral vagal PG reported in the literature [2].
The familial occurrence of paragangliomas has been 
well recognized and accounts for 10–40 % of cases [9, 15]. 
While no sex correlation exists, the familial form of the dis-
ease may become clinically apparent at a younger age [10]. 
In our study only one patient had a positive family history 
of PG and he was 40 years old at the initial presentation 
of the disease. The youngest patients in this study were 
14 years old at the time of diagnosis. In previous reports 
the youngest patients identified with this disease were 
16 years old [13]. As the morbidity of surgical treatment of 
PGs increases with their size, it is suggested that patients 
at risk should be screened by physical examination, urinary 
catecholamine analysis and magnetic resonance imaging of 
the head and neck every 1 or 2 years beginning with 14–
16 years of age to detect tumors at an early stage [13, 15].
Tumor growth in PGs is difficult to predict. Most PGs 
in the head and neck grow very slowly and remain asymp-
tomatic for years. However, there are cases of rapid tumor 
growth and this is particularly noticeable in some patients 
with familial form of the disease [3, 15]. We observed rapid 
progression of small synchronous carotid PG in the patient 
(No. 8, JA) after previous surgical removal of jugular and 
vagal tumor (Fig. 3a, b). This was the only patient in our 
group with familial history of paraganglioma.
Although the majority of paragangliomas and pheo-
chromocytomas are benign, both the sporadic and familial 
forms of PGs have the potential to be malignant. The cri-
teria of malignancy based on histopathology are not well 
defined and the only accepted evidence of malignancy is 
metastasis [15]. It is estimated that <5 % of all PGs are 
malignant [10, 15]. Malignancy is most common in vagal 
PGs [11]. In his study, Lee et al. [16] reviewed the records 
of the National Cancer Data Base from 1985 to 1996 and 
found 59 (0.07 %) malignant PGs. In this group 31 % of 
patients had distant metastases and about 69 % presented 
with regional lymph node metastases, which had much bet-
ter prognosis than the systemic ones. Neumann et al. [17] 
found 33 malignant tumors in an international study com-
prising 598 patients. In the present series of multiple para-
gangliomas no malignant tumors occurred and there was 
only one case of malignant vagal PG in the whole group of 
84 paraganglioma patients treated at our institution.
At the onset of the disease radiological imaging has two 
main goals: aid the clinical diagnosis and depict multiple 
tumors, which may occur synchronously or metachronously. 
Ultrasound has an established role in the management of neck 
tumors. Doppler US should be the first imaging procedure 
employed in patients with suspected carotid PG, as it demon-
strates abundant vascularity of PGs and facilitates differentiat-
ing them from other solid, non hypervascular neck masses or 
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enlarged vascular spaces, such as carotid artery aneurysm [2]. 
Identification of carotid PG implies complete US imaging of 
the neck and both bifurcations, as bilateral lesions may occur 
and synchronous vagal PG may also be present. However, US 
usually cannot delineate vagal PGs, as they are located farther 
cephalad in the neck, as well as the superior aspect of large 
carotid PGs. In such cases contrast-enhanced MRI should be 
performed to locate the tumor accurately (Fig. 4). US may 
also be used to assess carotid PG growth in follow-up of 
patients, when wait and scan policy was chosen. In patients 
with suspected jugular PG the initial imaging modality 
should be contrast-enhanced CT of the brain and skull base 
to delineate the tumor and a high resolution CT scan of the 
temporal bone to demonstrate typical for PGs bone changes, 
e.g. enlargement of the jugular foramen with erosion of its 
cortical margins [9, 18]. With better tissue characterization 
MRI may be helpful in further differential diagnosis and 
provides precise visualization of intracranial involvement 
in advanced tumors. Due to improved soft-tissue definition, 
this modality has been used as a non-invasive screening tech-
nique to detect subclinical synchronous neck PGs. Angiogra-
phy demonstrates typical for paragangliomas vascular blush 
and confirms the clinical diagnosis. It reliably rules out the 
presence of multiple synchronous tumors. For this purpose 
the diagnostic algorithm should include, apart from selective 
catheterization of ECA and ICA, contrast injection to both 
common carotid arteries to visualize potential small carotid 
PGs. Knowledge of the integrity of the contralateral cerebral 
circulation is essential to determine the management of the 
ipsilateral ICA during surgery and due to the risk of its grad-
ual occlusion after tumor removal, which was observed in 
two of our patients. Some authors perform angiographic bal-
loon test occlusion with transcranial Doppler monitoring to 
predict correctly hemodynamic outcome of potential sacrifice 
of the ICA [19]. However, in multiple paragangliomas, espe-
cially bilateral tumors, the decision: a sacrifice of the ICA 
versus subtotal resection should be thoroughly considered 
and should depend on the treatment planning of the opposite 
side tumors. Angiography is no longer mandatory in diagnos-
tic management, but is a last step in preoperative evaluation 
for selection of patients, who may benefit from preoperative 
embolization [3, 9]. We performed carotid angiography with 
embolization of tumor vessels only before surgery of jugular 
Fig. 3  Axial post-contrast CT 
scans demonstrate large carotid 
PG (a) (arrow) in a patient 
after single-stage infratempo-
ral removal of contralateral, 
synchronic jugular and vagal 
PGs (b)
Fig. 4  Coronal T1-weighted MR image after application of contrast 
medium shows thin border (arrowheads) between two ipsilateral 
tumors: vagal PG (black arrow) and carotid PG (white arrows)
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PGs and synchronic ipsilateral vagal PGs. Due to expanding 
capabilities of CT and MR angiography, non-invasive visuali-
zation of tumor vascular nature, arterial feeding branches and 
venous compression or invasion is possible [3].
Treatment options for head and neck paragangliomas 
include: surgery, conventional radiotherapy, stereotactic 
radiotherapy and stereotactic radiosurgery (for temporal 
bone PGs), permanent embolization and combination of 
these treatment modalities. The choice of treatment method 
depends on many factors, such as the age and general 
health of the patient, location and extensions of the tumor, 
tumor size and growth rate, carotid artery involvement, cra-
nial nerve deficits and potential risks connected with par-
ticular treatment modality.
Adequate tumor staging is important in discussing the 
optimal treatment modality, assessment of potential risks 
of surgery and selection of the surgical approach. Based on 
tumor location and extension, staging system introduced by 
Fisch et al. [8] is widely used for evaluation of temporal 
bone PGs. Shamblin et al. [20] introduced classification of 
carotid PGs reflecting the involvement of the carotid artery 
and difficulty of tumor resection.
Due to very slow progression of the disease, in some 
cases a wait and scan policy may be employed [3, 15]. 
Complete surgical resection is considered a treatment of 
choice for the majority of patients with carotid paragan-
gliomas [3, 5]. The optimal treatment for jugular and vagal 
PGs is more controversial. Potential risks of surgery for 
these tumors are permanent cranial nerve deficits resulting 
in vocal cord palsy and aspiration or pneumonia, as well as 
facial palsy for jugular PGs. As patients with preoperative 
lower cranial nerve palsy have time to compensate, they 
are better candidates for surgery, than those with normal 
nerves function. According to a review of over one thou-
sand operated jugular PGs, 1.6 % of patients died due to 
postoperative complications. In a group of 226 vagal PGs 
perioperative mortality rate was 1.3 % [15]. To avoid lower 
cranial nerve palsy, incomplete resection of large tumors in 
the jugular foramen with postoperative radiotherapy may 
be justified. Sivalingam et al. [21] apply two stage removal 
of tumors with intradural extension, e.g. neurosurgical and 
infratemporal fossa approach. In case of advanced intracra-
nial invasion, class Di3 tumors, palliative radiation therapy 
is advocated [3].
Conventional radiotherapy and stereotactic radio-
therapy have been initially used in cases of unresectable 
tumors, patients with poor general condition, or those who 
refused surgery. However, serious complications have 
been reported after irradiation of jugular PGs, including 
temporal bone osteomyelitis, temporal bone necrosis and 
risk of radiation induced malignancies [3, 22]. Currently 
the role of radiotherapy is increasing, with special inter-
est in stereotactic radiotherapy and radiosurgery, which 
spare adjacent normal tissues [23, 24]. Suarez et al. [15] 
reviewed 75 studies and compared the results of treatment 
of 1,084 patients with jugular PGs and of 226 patients with 
vagal PGs. They concluded that in patients with jugular 
PGs radiotherapy offers similar chance of tumor control 
with lower risk of morbidity in comparison with surgery. 
The authors suggest surgery only for patients with small 
jugular PG and radiotherapy for the rest. Surgery for vagal 
PGs should be reserved for patients that already have vagal 
nerve palsy.
Management of multiple paragangliomas is even more 
difficult. In management of such a rare and challenging dis-
ease, centralization of treatment would enable experienced 
institutions to specialize in this type of surgery and to 
reduce the mortality and morbidity. Special consideration 
is required in planning the initial and potential future treat-
ment. For patients with bilateral vagal and jugular tumors, 
every effort must be made to preserve vagal function and 
hearing at least on one side [15, 18]. Van der Mey et al. 
[25] indicate that a wait and scan policy should be consid-
ered for such patients. Surgery is advisable only in serious 
progressive cranial nerve deficits or life-threatening intrac-
ranial growth. As recognized in two of our patients after 
carotid body tumor resection, ipsilateral carotid diameter 
may decrease with time leading to ICA occlusion, which 
also has an impact on further treatment planning. In bilat-
eral tumors, Myssiorek et al. [1] suggest removal of small 
carotid PG prior to resection of contralateral large carotid 
or any vagal PG. If there is already a vagal nerve palsy due 
to the tumor or surgery, a contralateral carotid PG should 
be resected only in case of documented rapid growth. In 
multicentric disease, Boedeker [3] and Velegrakis et al. [26] 
suggest removing the largest tumor. The remaining PGs 
can be observed or radiated depending on the function of 
the cranial nerves. Sobol et al. [10] advise one step surgery 
for patients with unilateral multiple PGs. Similar approach 
was applied in our patients.
The follow-up is particularly important in management 
of paragangliomas. In case of a wait and scan strategy 
potential tumor growth may be monitored by means of MR 
imaging and the intervals between subsequent MR studies 
should depend on the clinical situation of each patient. The 
suggested follow-up interval in clinically stable patients is 
approximately 2 years. Progressive neurological deficits 
and deterioration require a shorter imaging intervals [18].
Postoperative follow-up is based on MRI and involves 
surveillance of the whole head and neck to detect multi-
centric tumors. To improve the visualization of recurrent 
paraganglioma in the temporal bone after surgery the use 
of fat-saturated contrast-enhanced T1-weighted images 
is very important. During first 5 years after operation 
6 months intervals are recommended. Thereafter, they may 
be stretched to 3 to 5 years [3].
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In postoperative follow-up of patients after resection of 
head and neck paraganglioma the possibility of metachro-
nous tumors should be considered. We have detected seven 
metachronous PGs in six patients 2–18 years after the first 
presentation of the disease. Apart from head and neck 
tumors, in one patient metachronic mediastinal PG devel-
oped. This confirms the importance of prolonged, regular 
follow-up of PG patients, which should include clinical 
examination and radiological imaging. Abdominal extra-
adrenal paragangliomas and pheochromocytomas usually 
hypersecrete catecholamines and produce certain clinical 
symptoms, therefore, physical examination and urinary cat-
echolamine analysis are useful screening methods for these 
tumors. In patients at risk abdominal ultrasound and MRI 
may be used as screening tools. This is particularly valuable 
in patients with hereditary paragangliomas, as multicentric-
ity is more frequent in this form of the disease. Functional 
imaging like radionuclide scintigraphy and positive emis-
sion tomography (PET) allow screening of the whole body 
to detect multiple tumors or metastatic disease [27].
Conclusions
Carotid body tumors are most common multiple PGs and 
most common bilateral tumors. In patients with head and 
neck PGs diagnostic imaging should always involve sur-
veillance of the whole head and neck to detect possible 
synchronous asymptomatic multicentric tumors. As mul-
tiple paragangliomas may develop many years after the 
presentation of the first tumor, regular, prolonged clinical 
and radiological follow-up of these patients is required. 
Apart from head and neck, other locations of metachro-
nous tumors should be also considered. Follow-up imaging 
should include evaluation of the ICA patency, as gradual 
occlusion of the artery may occur and influence further 
treatment planning. Management of multiple head and neck 
paragangliomas should take into account age and general 
condition of patients, size and location of tumors, cranial 
nerve function and possible synchronous tumors.
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